Aim: To determine the efficacy of platelet-rich plasma (PRP) injections for symptomatic tendinopathy.
Design: Systematic review of randomised, injection-controlled trials with meta-analysis.
Data Sources: Systematic searches of MEDLINE and EMBASE, supplemented by manual searches.
Eligibility Criteria For Selecting Studies: Randomised controlled trials with 3 months minimum follow-up that evaluated pain reduction with PRP versus control (saline, local anaesthetic, corticosteroid) injections in patients with symptomatic tendinopathy.
Results: A total of 16 randomised controlled trials (18 groups) of PRP versus control were included. Median sample size was 35 patients, a study size that would require an effect size ≥1.0 to achieve statistical significance. PRP was more efficacious than control in reducing tendinopathy pain, with an effect size of 0.47 (95% CI 0.22 to 0.72, p<0.001), signifying a moderate treatment effect. Heterogeneity among studies was moderate (I=67%, p<0.001). In subgroup analysis and meta-regression, studies with a higher proportion of female patients were associated with greater treatment benefits with PRP.
Conclusions: Injection of PRP is more efficacious than control injections in patients with symptomatic tendinopathy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687544 | PMC |
http://dx.doi.org/10.1136/bmjsem-2017-000237 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!